Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2026.04.29
CIRCULAR OF 2025 ANNUAL GENERAL MEETING
2026.04.29
PROXY FORM FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS
2026.04.29
NOTICE OF ANNUAL GENERAL MEETING
2026.04.29
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025
2026.04.29
2025 ANNUAL REPORT
2026.04.17
DATE OF BOARD MEETING
2026.03.31
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 AND PROPOSED CH...
2026.03.17
DATE OF BOARD MEETING
2025.12.18
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2025.12.18
POLL RESULTS OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 16...
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
